Knobbe Martens Named Among Top Patent Prosecution Leaders in Patexia Report
IRVINE, Calif., April 1, 2026 – Knobbe Martens is pleased to share that the firm and several of its partners were highlighted in Patexia’s 2026 Patent Prosecution Leaders report for...
IP Considerations Following FDA Announcement on Flexibility for Cell and Gene Therapies
Key Takeaways: Manufacturing processes of cell and gene therapies (CGTs) may remain fluid well into development and even after FDA approval, and therefore sponsors of CGTs may benefit from patent...
USPTO’s Supplemental Guidance on Design Patents for Computer-Generated Interfaces and Icons
Key Takeaway: The USPTO has revised its design patent guidance to better reflect evolving digital interface technologies, including projections and augmented or virtual reality environments. The updated guidance provides design...
Subscribe for News and Updates
